Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior
- PMID: 38861355
- PMCID: PMC11372814
- DOI: 10.1182/bloodadvances.2023011506
Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior
Abstract
Burkitt lymphoma (BL) is characterized by a tumor microenvironment (TME) in which macrophages represent the main component, determining a distinct histological appearance known as "starry sky" pattern. However, in some instances, BL may exhibit a granulomatous reaction that has been previously linked to favorable prognosis and spontaneous regression. The aim of our study was to deeply characterize the immune landscape of 7 cases of Epstein-Barr virus-positive (EBV+) BL with granulomatous reaction compared with 8 cases of EBV+ BL and 8 EBV-negative (EBV-) BL, both with typical starry sky pattern, by Gene expression profiling performed on the NanoString nCounter platform. Subsequently, the data were validated using multiplex and combined immunostaining. Based on unsupervised clustering of differentially expressed genes, BL samples formed 3 distinct clusters differentially enriched in BL with a diffuse granulomatous reaction (cluster 1), EBV+ BL with typical starry sky pattern (cluster 2), EBV- BL with typical "starry sky" (cluster 3). We observed variations in the immune response signature among BL with granulomatous reaction and BL with typical "starry sky," both EBV+ and EBV-. The TME signature in BL with diffuse granulomatous reaction showed a proinflammatory response, whereas BLs with "starry sky" were characterized by upregulation of M2 polarization and protumor response. Moreover, the analysis of additional signatures revealed an upregulation of the dark zone signature and epigenetic signature in BL with a typical starry sky. Tumor-associated macrophages and epigenetic regulators may be promising targets for additional therapies for BL lymphoma, opening novel immunotherapeutic strategies.
© 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures
Similar articles
-
Early stage of Epstein-Barr virus lytic infection leading to the "starry sky" pattern formation in endemic Burkitt lymphoma.Arch Pathol Lab Med. 2004 May;128(5):549-52. doi: 10.5858/2004-128-549-ESOEVL. Arch Pathol Lab Med. 2004. PMID: 15086279
-
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression.Histopathology. 2022 Jan;80(2):430-442. doi: 10.1111/his.14391. Epub 2021 Jul 5. Histopathology. 2022. PMID: 33948980 Free PMC article.
-
Subtyping Burkitt Lymphoma by DNA Methylation.Genes Chromosomes Cancer. 2025 Apr;64(4):e70042. doi: 10.1002/gcc.70042. Genes Chromosomes Cancer. 2025. PMID: 40192513 Free PMC article.
-
Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe.Pediatr Blood Cancer. 2019 Jul;66(7):e27752. doi: 10.1002/pbc.27752. Epub 2019 Apr 12. Pediatr Blood Cancer. 2019. PMID: 30977593 Review.
-
Burkitt lymphoma and MYC: what else is new?Adv Anat Pathol. 2014 May;21(3):160-5. doi: 10.1097/PAP.0b013e3182a92cde. Adv Anat Pathol. 2014. PMID: 24713985 Review.
References
-
- Scott DW, Gascoyne RD. The tumour microenvironment in B cell lymphomas. Nat Rev Cancer. 2014;14(8):517–534. 2014;14(8):517-534. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
